Overview

A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain

Status:
Completed

Trial end date:
2014-10-01

Target enrollment:

Participant gender:

Summary

The primary objective is to assess the efficacy of oxycodone/naloxone controlled-release tablets (OXN) for the management of opioid-induced constipation (OIC) compared with oxycodone controlled-release tablets (OXY) in subjects with moderate to severe low back pain and opioid-induced constipation who require around-the-clock opioid therapy.

Phase:

Phase 3

Details

Lead Sponsor:

Purdue Pharma LP

Treatments:

Analgesics
Analgesics, Opioid
Naloxone
Oxycodone